Readable research linked to original sources

Articles

Browse normalized, publication-ready research with direct links to its evidence and source.

2 articles

Newest first

Research Article 2025CC BYFree full text

Partial Dopamine D2/3 Agonists and Dual Disorders: A Retrospective-Cohort Study in a Real-World Clinical Setting on Patients with Schizophrenia Spectrum Disorders and Cannabis Use Disorder.

Giada Trovini, Ginevra Lombardozzi, Georgios D. Kotzalidis, Ilaria Pagano, Emanuela Amici, Valeria Giovanetti +3 more

Introduction/objective Schizophrenia with substance use disorder is a complex clinical condition that may increase treatment resistance. Cannabis use disorder is frequently associated with psychosis and the causal link has still to be defined. Partial D2/3 agonists may ensure limbic dopamine release normalization while avoiding reduced frontocortical dopamine release, which would contribute to negative symptoms. W…

Current Neuropharmacology Europe PMC

Open article record in new tab ↗

Research Article 2023CC BYFree full text

A comprehensive evaluation of adverse childhood experiences, social–emotional impairments, and neurodevelopmental disorders in cannabis-use disorder: Implications for clinical practice

Giada Trovini, Emanuela Amici, Piergiorgio Bauco, Marta Matrone, Ginevra Lombardozzi, Valeria Giovanetti +2 more

BackgroundAdverse childhood experiences (ACEs), social–emotional impairments (SEIs), and neurodevelopmental disorders (NDs) are frequent in psychiatric disorders, including substance-use disorders. We aimed to determine the prevalence of ACE, SEI, or ND in individuals with cannabis-use disorder (CUD). We compared individuals with preCUD-onset ACE, SEI, or ND to those without.MethodsWe crosssectionally studied 323…

European Psychiatry